期刊
ONCOTARGET
卷 6, 期 8, 页码 5597-5614出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.3343
关键词
CXCR4; DLBCL; BCL2; Myc; TP53 mutation
资金
- University of Texas MD Anderson Cancer Center Institutional Research Grant Award
- MD Anderson Lymphoma and Myeloma Specialized Programs of Research Excellence (SPORE) Research Development Program Awards
- MD Anderson Collaborative Research Funds with High-Throughput Molecular Diagnostics
- Gilead Pharmaceutical
- Roche Molecular Systems
- National Cancer Institute
- National Institutes of Health [R01CA138688, R01CA187415]
- Medical School of Taizhou University Scholarship Award
- MD Anderson Pathology Fellowship Award
- Harold C. and Mary L. Daily Endowment Fellowships
- Shannon Timmins Fellowship for Leukemia Research Award
Abnormal expression of the chemokine receptor CXCR4 plays an essential role in tumor cell dissemination and disease progression. However, the significance of CXCR4 overexpression in de novo diffuse large B cell lymphoma (DLBCL) is unknown. In 743 patients with de novo diffuse large B cell lymphoma (DLBCL) who received standard Rituximab-CHOP immunochemotherapy, we assessed the expression of CXCR4 and dissected its prognostic significance in various DLBCL subsets. Our results showed that CXCR4(+) patients was associated with male, bulky tumor, high Ki-67 index, activated B-cell-like (ABC) subtype, and Myc, Bcl-2 or p53 overexpression. Moreover, CXCR4(+) was an independent factor predicting poorer progression-free survival in germinal-center B-cell-like (GCB)-DLBCL, but not in ABC-DLBCL; and in patients with an IPI of <= 2, but not in those with an IPI>2. The lack of prognostic significance of CXCR4 in ABC-DLBCL was likely due to the activation of p53 tumor suppressor attenuating CXCR4 signaling. Furthermore, concurrent CXCR4(+) and BCL2 translocation showed dismal outcomes resembling but independent of MYC/BCL2 double-hit DLBCL. Gene expression profiling suggested that alterations in the tumor microenvironment and immune responses, increased tumor proliferation and survival, and the dissemination of CXCR4(+) tumor cells to distant organs or tissues were underlying molecular mechanisms responsible for the CXCR4(+) associated poor prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据